DR. GIRISH SOMASHEKHAR MUNAVALLI, M.D.
Osteopathic Medicine at Randolph Rd, Charlotte, NC
License number
North Carolina 200400240
Category
Osteopathic Medicine
Type
MOHS-Micrographic Surgery
License number
North Carolina 200400240
Category
Osteopathic Medicine
Type
Procedural Dermatology
Address
Address
1918 Randolph Rd SUITE 550, Charlotte, NC 28207
Phone
(704) 375-6766
(704) 332-6552 (Fax)
(410) 666-3981 (Fax)
(704) 332-6552 (Fax)
(410) 666-3981 (Fax)
Professional information
Girish Somashekhar Munavalli, Charlotte NC
Specialties:
Dermatologist
Address:
1918 Randolph Rd, Charlotte, NC 28207
Board certifications:
American Board of Dermatology Certification in Dermatology
Dr. Girish S Munavalli, Charlotte NC - MD (Doctor of Medicine)
Specialties:
Dermatology
Address:
1918 Randolph Rd STE 550, Charlotte 28207
(704) 375-6766 (Phone)
(704) 375-6766 (Phone)
Languages:
English
Hospitals:
1918 Randolph Rd STE 550, Charlotte 28207
Johns Hopkins Bayview Medical Center
4940 Eastern Ave, Baltimore 21224
University of Maryland Medical Center
22 South Greene St, Baltimore 21201
Johns Hopkins Bayview Medical Center
4940 Eastern Ave, Baltimore 21224
University of Maryland Medical Center
22 South Greene St, Baltimore 21201
Education:
Medical School
Mayo Medical School
Emory University School Of Med
Mayo Medical School
Emory University School Of Med
Combination Therapy With Low Dosage Strength Imiquimod And Photodynamic Therapy To Treat Actinic Keratosis
US Patent:
2013019, Jul 25, 2013
Filed:
Sep 14, 2012
Appl. No.:
13/619983
Inventors:
Michael H. Gold - Nashville TN, US
Joel L. Cohen - Denver CO, US
Girish S. Munavalli - Charlotte NC, US
Tze-Chiang Meng - Lino Lakes MN, US
Joel L. Cohen - Denver CO, US
Girish S. Munavalli - Charlotte NC, US
Tze-Chiang Meng - Lino Lakes MN, US
Assignee:
Medicis Pharmaceutical Corporation - Scottsdale AZ
International Classification:
A61N 5/06
US Classification:
604501
Abstract:
This disclosure is directed to the use of complementary or combination photodynamic therapy and topical therapy with a lower dosage strength imiquimod formulation for treating actinic keratosis.